Compile Data Set for Download or QSAR
Report error Found 435 Enz. Inhib. hit(s) with all data for entry = 940
TargetTyrosine-protein kinase receptor UFO(Human)
Pfizer

US Patent
LigandChemical structure of BindingDB Monomer ID 299749BDBM299749(4-[4-({[2-amino-5- (1-methyl-1H- imidazol-4- yl)py...)
Affinity DataKi:  0.0100nMAssay Description:AXL enzyme inhibition (% inhibition, Kiapp and Ki values) by small molecule inhibitors was evaluated using a fluorescence-based microfluidic mobility...More data for this Ligand-Target Pair
In Depth
Date in BDB:
3/15/2019
Entry Details
US Patent

TargetTyrosine-protein kinase receptor UFO(Human)
Pfizer

US Patent
LigandChemical structure of BindingDB Monomer ID 299975BDBM299975(4-[4-({[2-amino-5- (1-methyl-1H- imidazol-4- yl)py...)
Affinity DataKi:  0.0120nMAssay Description:AXL enzyme inhibition (% inhibition, Kiapp and Ki values) by small molecule inhibitors was evaluated using a fluorescence-based microfluidic mobility...More data for this Ligand-Target Pair
In Depth
Date in BDB:
3/15/2019
Entry Details
US Patent

TargetTyrosine-protein kinase receptor UFO(Human)
Pfizer

US Patent
LigandChemical structure of BindingDB Monomer ID 299902BDBM299902(US9593097, Example 280 | 6-[4-({[2-amino-5- (1-met...)
Affinity DataKi:  0.0120nMAssay Description:AXL enzyme inhibition (% inhibition, Kiapp and Ki values) by small molecule inhibitors was evaluated using a fluorescence-based microfluidic mobility...More data for this Ligand-Target Pair
In Depth
Date in BDB:
3/15/2019
Entry Details
US Patent

TargetTyrosine-protein kinase receptor UFO(Human)
Pfizer

US Patent
LigandChemical structure of BindingDB Monomer ID 300079BDBM300079(N-[(2R)-1- hydroxypropan-2- yl]-6-[4-(4- methoxy-1...)
Affinity DataKi: <0.0130nMAssay Description:AXL enzyme inhibition (% inhibition, Kiapp and Ki values) by small molecule inhibitors was evaluated using a fluorescence-based microfluidic mobility...More data for this Ligand-Target Pair
In Depth
Date in BDB:
3/15/2019
Entry Details
US Patent

TargetTyrosine-protein kinase receptor UFO(Human)
Pfizer

US Patent
LigandChemical structure of BindingDB Monomer ID 300035BDBM300035(2-(benzyloxy)-N- [(2R)-1- hydroxypropan-2- yl]-6-[...)
Affinity DataKi: <0.0130nMAssay Description:AXL enzyme inhibition (% inhibition, Kiapp and Ki values) by small molecule inhibitors was evaluated using a fluorescence-based microfluidic mobility...More data for this Ligand-Target Pair
In Depth
Date in BDB:
3/15/2019
Entry Details
US Patent

TargetTyrosine-protein kinase receptor UFO(Human)
Pfizer

US Patent
LigandChemical structure of BindingDB Monomer ID 300011BDBM300011(4-[4-({[2-amino-5- (1-methyl-1H- imidazol-4- yl)py...)
Affinity DataKi: <0.0130nMAssay Description:AXL enzyme inhibition (% inhibition, Kiapp and Ki values) by small molecule inhibitors was evaluated using a fluorescence-based microfluidic mobility...More data for this Ligand-Target Pair
In Depth
Date in BDB:
3/15/2019
Entry Details
US Patent

TargetTyrosine-protein kinase receptor UFO(Human)
Pfizer

US Patent
LigandChemical structure of BindingDB Monomer ID 300077BDBM300077(US9593097, Example 458 | N-(3-amino-3- methylbutan...)
Affinity DataKi: <0.0130nMAssay Description:AXL enzyme inhibition (% inhibition, Kiapp and Ki values) by small molecule inhibitors was evaluated using a fluorescence-based microfluidic mobility...More data for this Ligand-Target Pair
In Depth
Date in BDB:
3/15/2019
Entry Details
US Patent

TargetTyrosine-protein kinase receptor UFO(Human)
Pfizer

US Patent
LigandChemical structure of BindingDB Monomer ID 300088BDBM300088(N-[(2R)-1- hydroxypropan-2- yl]-2-[(2R)-2- methoxy...)
Affinity DataKi:  0.0140nMAssay Description:AXL enzyme inhibition (% inhibition, Kiapp and Ki values) by small molecule inhibitors was evaluated using a fluorescence-based microfluidic mobility...More data for this Ligand-Target Pair
In Depth
Date in BDB:
3/15/2019
Entry Details
US Patent

TargetTyrosine-protein kinase receptor UFO(Human)
Pfizer

US Patent
LigandChemical structure of BindingDB Monomer ID 299931BDBM299931(4-[4-({[2-amino-5- (1-methyl-1H- imidazol-4- yl)py...)
Affinity DataKi:  0.0150nMAssay Description:AXL enzyme inhibition (% inhibition, Kiapp and Ki values) by small molecule inhibitors was evaluated using a fluorescence-based microfluidic mobility...More data for this Ligand-Target Pair
In Depth
Date in BDB:
3/15/2019
Entry Details
US Patent

TargetTyrosine-protein kinase receptor UFO(Human)
Pfizer

US Patent
LigandChemical structure of BindingDB Monomer ID 299998BDBM299998(N-[(2R)-1- hydroxypropan-2- yl]-6-[4-(4- methoxy-1...)
Affinity DataKi:  0.0150nMAssay Description:AXL enzyme inhibition (% inhibition, Kiapp and Ki values) by small molecule inhibitors was evaluated using a fluorescence-based microfluidic mobility...More data for this Ligand-Target Pair
In Depth
Date in BDB:
3/15/2019
Entry Details
US Patent

TargetTyrosine-protein kinase receptor UFO(Human)
Pfizer

US Patent
LigandChemical structure of BindingDB Monomer ID 299744BDBM299744(4-[4-({[2-amino-5- (1-methyl-1H- imidazol-4- yl)py...)
Affinity DataKi:  0.0160nMAssay Description:AXL enzyme inhibition (% inhibition, Kiapp and Ki values) by small molecule inhibitors was evaluated using a fluorescence-based microfluidic mobility...More data for this Ligand-Target Pair
In Depth
Date in BDB:
3/15/2019
Entry Details
US Patent

TargetTyrosine-protein kinase receptor UFO(Human)
Pfizer

US Patent
LigandChemical structure of BindingDB Monomer ID 299909BDBM299909(4-[4-({[2-amino-5- (1-methyl-1H- imidazol-4- yl)py...)
Affinity DataKi:  0.0160nMAssay Description:AXL enzyme inhibition (% inhibition, Kiapp and Ki values) by small molecule inhibitors was evaluated using a fluorescence-based microfluidic mobility...More data for this Ligand-Target Pair
In Depth
Date in BDB:
3/15/2019
Entry Details
US Patent

TargetTyrosine-protein kinase receptor UFO(Human)
Pfizer

US Patent
LigandChemical structure of BindingDB Monomer ID 300012BDBM300012(N-(2- methoxyethyl)-6- [4-(4-methoxy-1H- pyrrolo[2...)
Affinity DataKi:  0.0160nMAssay Description:AXL enzyme inhibition (% inhibition, Kiapp and Ki values) by small molecule inhibitors was evaluated using a fluorescence-based microfluidic mobility...More data for this Ligand-Target Pair
In Depth
Date in BDB:
3/15/2019
Entry Details
US Patent

TargetTyrosine-protein kinase receptor UFO(Human)
Pfizer

US Patent
LigandChemical structure of BindingDB Monomer ID 300049BDBM300049((3,3- difluoroazetidin-1- yl)(2-{[(2R)-1- methoxyp...)
Affinity DataKi:  0.0180nMAssay Description:AXL enzyme inhibition (% inhibition, Kiapp and Ki values) by small molecule inhibitors was evaluated using a fluorescence-based microfluidic mobility...More data for this Ligand-Target Pair
In Depth
Date in BDB:
3/15/2019
Entry Details
US Patent

TargetTyrosine-protein kinase receptor UFO(Human)
Pfizer

US Patent
LigandChemical structure of BindingDB Monomer ID 300007BDBM300007(2-[(1- cyanocyclopropyl) methoxy]-N-[(2R)- 1-hydro...)
Affinity DataKi: <0.0180nMAssay Description:AXL enzyme inhibition (% inhibition, Kiapp and Ki values) by small molecule inhibitors was evaluated using a fluorescence-based microfluidic mobility...More data for this Ligand-Target Pair
In Depth
Date in BDB:
3/15/2019
Entry Details
US Patent

TargetTyrosine-protein kinase receptor UFO(Human)
Pfizer

US Patent
LigandChemical structure of BindingDB Monomer ID 299893BDBM299893(4-[4-({[2-amino-5- (1-methyl-1H- imidazol-4- yl)py...)
Affinity DataKi:  0.0190nMAssay Description:AXL enzyme inhibition (% inhibition, Kiapp and Ki values) by small molecule inhibitors was evaluated using a fluorescence-based microfluidic mobility...More data for this Ligand-Target Pair
In Depth
Date in BDB:
3/15/2019
Entry Details
US Patent

TargetTyrosine-protein kinase receptor UFO(Human)
Pfizer

US Patent
LigandChemical structure of BindingDB Monomer ID 300070BDBM300070(N-[(2R)-3- hydroxy-3- methylbutan-2-yl]- 4-[4-(4-m...)
Affinity DataKi:  0.0200nMAssay Description:AXL enzyme inhibition (% inhibition, Kiapp and Ki values) by small molecule inhibitors was evaluated using a fluorescence-based microfluidic mobility...More data for this Ligand-Target Pair
In Depth
Date in BDB:
3/15/2019
Entry Details
US Patent

TargetTyrosine-protein kinase receptor UFO(Human)
Pfizer

US Patent
LigandChemical structure of BindingDB Monomer ID 300090BDBM300090(N-[(2R)-1- hydroxypropan-2- yl]-2-[(2S)-2- methoxy...)
Affinity DataKi:  0.0200nMAssay Description:AXL enzyme inhibition (% inhibition, Kiapp and Ki values) by small molecule inhibitors was evaluated using a fluorescence-based microfluidic mobility...More data for this Ligand-Target Pair
In Depth
Date in BDB:
3/15/2019
Entry Details
US Patent

TargetTyrosine-protein kinase receptor UFO(Human)
Pfizer

US Patent
LigandChemical structure of BindingDB Monomer ID 299917BDBM299917(4-[4-({[2-amino-5- (1-methyl-1H- imidazol-4- yl)py...)
Affinity DataKi:  0.0200nMAssay Description:AXL enzyme inhibition (% inhibition, Kiapp and Ki values) by small molecule inhibitors was evaluated using a fluorescence-based microfluidic mobility...More data for this Ligand-Target Pair
In Depth
Date in BDB:
3/15/2019
Entry Details
US Patent

TargetTyrosine-protein kinase receptor UFO(Human)
Pfizer

US Patent
LigandChemical structure of BindingDB Monomer ID 299901BDBM299901(4-[4-({[2-amino-5- (1-methyl-1H- imidazol-4- yl)py...)
Affinity DataKi:  0.0210nMAssay Description:AXL enzyme inhibition (% inhibition, Kiapp and Ki values) by small molecule inhibitors was evaluated using a fluorescence-based microfluidic mobility...More data for this Ligand-Target Pair
In Depth
Date in BDB:
3/15/2019
Entry Details
US Patent

TargetTyrosine-protein kinase receptor UFO(Human)
Pfizer

US Patent
LigandChemical structure of BindingDB Monomer ID 299996BDBM299996(4-[(1- cyanocyclopropyl) methoxy]-6-[4-(4- methoxy...)
Affinity DataKi:  0.0210nMAssay Description:AXL enzyme inhibition (% inhibition, Kiapp and Ki values) by small molecule inhibitors was evaluated using a fluorescence-based microfluidic mobility...More data for this Ligand-Target Pair
In Depth
Date in BDB:
3/15/2019
Entry Details
US Patent

TargetTyrosine-protein kinase receptor UFO(Human)
Pfizer

US Patent
LigandChemical structure of BindingDB Monomer ID 300125BDBM300125(N-cyclobutyl-4- {[(2R)-1- methoxypropan-2- yl]oxy}...)
Affinity DataKi:  0.0210nMAssay Description:AXL enzyme inhibition (% inhibition, Kiapp and Ki values) by small molecule inhibitors was evaluated using a fluorescence-based microfluidic mobility...More data for this Ligand-Target Pair
In Depth
Date in BDB:
3/15/2019
Entry Details
US Patent

TargetTyrosine-protein kinase receptor UFO(Human)
Pfizer

US Patent
LigandChemical structure of BindingDB Monomer ID 300104BDBM300104(4-(benzyloxy)-N- [(2R)-1- hydroxypropan-2- yl]-6-[...)
Affinity DataKi:  0.0250nMAssay Description:AXL enzyme inhibition (% inhibition, Kiapp and Ki values) by small molecule inhibitors was evaluated using a fluorescence-based microfluidic mobility...More data for this Ligand-Target Pair
In Depth
Date in BDB:
3/15/2019
Entry Details
US Patent

TargetTyrosine-protein kinase receptor UFO(Human)
Pfizer

US Patent
LigandChemical structure of BindingDB Monomer ID 299891BDBM299891(4-[4-({[2-amino-5- (1-methyl-1H- imidazol-4- yl)py...)
Affinity DataKi:  0.0260nMAssay Description:AXL enzyme inhibition (% inhibition, Kiapp and Ki values) by small molecule inhibitors was evaluated using a fluorescence-based microfluidic mobility...More data for this Ligand-Target Pair
In Depth
Date in BDB:
3/15/2019
Entry Details
US Patent

TargetTyrosine-protein kinase receptor UFO(Human)
Pfizer

US Patent
LigandChemical structure of BindingDB Monomer ID 300064BDBM300064(N-[(2R)-1- hydroxypropan-2- yl]-4-{[(2R)-1- methox...)
Affinity DataKi:  0.0280nMAssay Description:AXL enzyme inhibition (% inhibition, Kiapp and Ki values) by small molecule inhibitors was evaluated using a fluorescence-based microfluidic mobility...More data for this Ligand-Target Pair
In Depth
Date in BDB:
3/15/2019
Entry Details
US Patent

TargetTyrosine-protein kinase receptor UFO(Human)
Pfizer

US Patent
LigandChemical structure of BindingDB Monomer ID 299746BDBM299746(4-[4-({[2-amino-5- (1-methyl-1H- imidazol-4- yl)py...)
Affinity DataKi:  0.0280nMAssay Description:AXL enzyme inhibition (% inhibition, Kiapp and Ki values) by small molecule inhibitors was evaluated using a fluorescence-based microfluidic mobility...More data for this Ligand-Target Pair
In Depth
Date in BDB:
3/15/2019
Entry Details
US Patent

TargetTyrosine-protein kinase receptor UFO(Human)
Pfizer

US Patent
LigandChemical structure of BindingDB Monomer ID 299890BDBM299890(4-[4-({[2-amino-5- (1-methyl-1H- imidazol-4- yl)py...)
Affinity DataKi:  0.0280nMAssay Description:AXL enzyme inhibition (% inhibition, Kiapp and Ki values) by small molecule inhibitors was evaluated using a fluorescence-based microfluidic mobility...More data for this Ligand-Target Pair
In Depth
Date in BDB:
3/15/2019
Entry Details
US Patent

TargetTyrosine-protein kinase receptor UFO(Human)
Pfizer

US Patent
LigandChemical structure of BindingDB Monomer ID 299930BDBM299930(4-[4-({[2-amino-5- (1-methyl-1H- imidazol-4- yl)py...)
Affinity DataKi:  0.0290nMAssay Description:AXL enzyme inhibition (% inhibition, Kiapp and Ki values) by small molecule inhibitors was evaluated using a fluorescence-based microfluidic mobility...More data for this Ligand-Target Pair
In Depth
Date in BDB:
3/15/2019
Entry Details
US Patent

TargetTyrosine-protein kinase receptor UFO(Human)
Pfizer

US Patent
LigandChemical structure of BindingDB Monomer ID 300071BDBM300071(N-[(2R)-1- hydroxypropan-2- yl]-4-[4-(4- methoxy-1...)
Affinity DataKi:  0.0300nMAssay Description:AXL enzyme inhibition (% inhibition, Kiapp and Ki values) by small molecule inhibitors was evaluated using a fluorescence-based microfluidic mobility...More data for this Ligand-Target Pair
In Depth
Date in BDB:
3/15/2019
Entry Details
US Patent

TargetTyrosine-protein kinase receptor UFO(Human)
Pfizer

US Patent
LigandChemical structure of BindingDB Monomer ID 300103BDBM300103(4-[(1- cyanocyclopropyl) methoxy]-N-[(2R)- 1-hydro...)
Affinity DataKi:  0.0300nMAssay Description:AXL enzyme inhibition (% inhibition, Kiapp and Ki values) by small molecule inhibitors was evaluated using a fluorescence-based microfluidic mobility...More data for this Ligand-Target Pair
In Depth
Date in BDB:
3/15/2019
Entry Details
US Patent

TargetTyrosine-protein kinase receptor UFO(Human)
Pfizer

US Patent
LigandChemical structure of BindingDB Monomer ID 299803BDBM299803(N- (bicyclo[1.1.1]pent- 1-yl)-4-{[(1S,2R)- 2- cyan...)
Affinity DataKi:  0.0300nMAssay Description:AXL enzyme inhibition (% inhibition, Kiapp and Ki values) by small molecule inhibitors was evaluated using a fluorescence-based microfluidic mobility...More data for this Ligand-Target Pair
In Depth
Date in BDB:
3/15/2019
Entry Details
US Patent

TargetTyrosine-protein kinase receptor UFO(Human)
Pfizer

US Patent
LigandChemical structure of BindingDB Monomer ID 300099BDBM300099(4-{[(1S,2R)-2- cyanocyclopropyl] methoxy}-N-[(2R)-...)
Affinity DataKi:  0.0320nMAssay Description:AXL enzyme inhibition (% inhibition, Kiapp and Ki values) by small molecule inhibitors was evaluated using a fluorescence-based microfluidic mobility...More data for this Ligand-Target Pair
In Depth
Date in BDB:
3/15/2019
Entry Details
US Patent

TargetTyrosine-protein kinase receptor UFO(Human)
Pfizer

US Patent
LigandChemical structure of BindingDB Monomer ID 299852BDBM299852(4-[4-({[2-amino-5- (1-methyl-1H- imidazol-4- yl)py...)
Affinity DataKi:  0.0320nMAssay Description:AXL enzyme inhibition (% inhibition, Kiapp and Ki values) by small molecule inhibitors was evaluated using a fluorescence-based microfluidic mobility...More data for this Ligand-Target Pair
In Depth
Date in BDB:
3/15/2019
Entry Details
US Patent

TargetTyrosine-protein kinase receptor UFO(Human)
Pfizer

US Patent
LigandChemical structure of BindingDB Monomer ID 299922BDBM299922(6-[4-({[2-amino-5- (1-methyl-1H- imidazol-4- yl)py...)
Affinity DataKi:  0.0330nMAssay Description:AXL enzyme inhibition (% inhibition, Kiapp and Ki values) by small molecule inhibitors was evaluated using a fluorescence-based microfluidic mobility...More data for this Ligand-Target Pair
In Depth
Date in BDB:
3/15/2019
Entry Details
US Patent

TargetTyrosine-protein kinase receptor UFO(Human)
Pfizer

US Patent
LigandChemical structure of BindingDB Monomer ID 299911BDBM299911(4-[4-({[2-amino-5- (1-methyl-1H- imidazol-4- yl)py...)
Affinity DataKi:  0.0340nMAssay Description:AXL enzyme inhibition (% inhibition, Kiapp and Ki values) by small molecule inhibitors was evaluated using a fluorescence-based microfluidic mobility...More data for this Ligand-Target Pair
In Depth
Date in BDB:
3/15/2019
Entry Details
US Patent

TargetTyrosine-protein kinase receptor UFO(Human)
Pfizer

US Patent
LigandChemical structure of BindingDB Monomer ID 300087BDBM300087(N-[(1R,2R)-2- hydroxy- cyclobutyl]- 6-[4-(4-methox...)
Affinity DataKi:  0.0340nMAssay Description:AXL enzyme inhibition (% inhibition, Kiapp and Ki values) by small molecule inhibitors was evaluated using a fluorescence-based microfluidic mobility...More data for this Ligand-Target Pair
In Depth
Date in BDB:
3/15/2019
Entry Details
US Patent

TargetTyrosine-protein kinase receptor UFO(Human)
Pfizer

US Patent
LigandChemical structure of BindingDB Monomer ID 300056BDBM300056(US9593097, Example 436 | N-(3-amino-3- methylbutan...)
Affinity DataKi:  0.0340nMAssay Description:AXL enzyme inhibition (% inhibition, Kiapp and Ki values) by small molecule inhibitors was evaluated using a fluorescence-based microfluidic mobility...More data for this Ligand-Target Pair
In Depth
Date in BDB:
3/15/2019
Entry Details
US Patent

TargetTyrosine-protein kinase receptor UFO(Human)
Pfizer

US Patent
LigandChemical structure of BindingDB Monomer ID 300098BDBM300098(4-{[(1S,2R)-2- cyanocyclopropyl] methoxy}-N-[(2R)-...)
Affinity DataKi:  0.0350nMAssay Description:AXL enzyme inhibition (% inhibition, Kiapp and Ki values) by small molecule inhibitors was evaluated using a fluorescence-based microfluidic mobility...More data for this Ligand-Target Pair
In Depth
Date in BDB:
3/15/2019
Entry Details
US Patent

TargetTyrosine-protein kinase receptor UFO(Human)
Pfizer

US Patent
LigandChemical structure of BindingDB Monomer ID 300101BDBM300101(4-(benzyloxy)-N- [(2R)-1- hydroxypropan-2- yl]-6-[...)
Affinity DataKi:  0.0370nMAssay Description:AXL enzyme inhibition (% inhibition, Kiapp and Ki values) by small molecule inhibitors was evaluated using a fluorescence-based microfluidic mobility...More data for this Ligand-Target Pair
In Depth
Date in BDB:
3/15/2019
Entry Details
US Patent

TargetTyrosine-protein kinase receptor UFO(Human)
Pfizer

US Patent
LigandChemical structure of BindingDB Monomer ID 300063BDBM300063(N-[(2R)-3- hydroxy-3- methylbutan-2-yl]- 4-{[(2R)-...)
Affinity DataKi:  0.0380nMAssay Description:AXL enzyme inhibition (% inhibition, Kiapp and Ki values) by small molecule inhibitors was evaluated using a fluorescence-based microfluidic mobility...More data for this Ligand-Target Pair
In Depth
Date in BDB:
3/15/2019
Entry Details
US Patent

TargetTyrosine-protein kinase receptor UFO(Human)
Pfizer

US Patent
LigandChemical structure of BindingDB Monomer ID 300102BDBM300102(4-[(1- cyanocyclopropyl) methoxy]-N-[(2R)- 3-hydro...)
Affinity DataKi:  0.0380nMAssay Description:AXL enzyme inhibition (% inhibition, Kiapp and Ki values) by small molecule inhibitors was evaluated using a fluorescence-based microfluidic mobility...More data for this Ligand-Target Pair
In Depth
Date in BDB:
3/15/2019
Entry Details
US Patent

TargetTyrosine-protein kinase receptor UFO(Human)
Pfizer

US Patent
LigandChemical structure of BindingDB Monomer ID 299849BDBM299849(4-[4-({[2-amino-5- (1-methyl-1H- imidazol-4- yl)py...)
Affinity DataKi:  0.0390nMAssay Description:AXL enzyme inhibition (% inhibition, Kiapp and Ki values) by small molecule inhibitors was evaluated using a fluorescence-based microfluidic mobility...More data for this Ligand-Target Pair
In Depth
Date in BDB:
3/15/2019
Entry Details
US Patent

TargetTyrosine-protein kinase receptor UFO(Human)
Pfizer

US Patent
LigandChemical structure of BindingDB Monomer ID 299876BDBM299876(4-[4-({[2-amino-5- (1-methyl-1H- imidazol-4- yl)py...)
Affinity DataKi:  0.0400nMAssay Description:AXL enzyme inhibition (% inhibition, Kiapp and Ki values) by small molecule inhibitors was evaluated using a fluorescence-based microfluidic mobility...More data for this Ligand-Target Pair
In Depth
Date in BDB:
3/15/2019
Entry Details
US Patent

TargetTyrosine-protein kinase receptor UFO(Human)
Pfizer

US Patent
LigandChemical structure of BindingDB Monomer ID 300061BDBM300061(N-(3-amino-3- methylbutan-2-yl)- 2-[(1- cyanocyclo...)
Affinity DataKi:  0.0400nMAssay Description:AXL enzyme inhibition (% inhibition, Kiapp and Ki values) by small molecule inhibitors was evaluated using a fluorescence-based microfluidic mobility...More data for this Ligand-Target Pair
In Depth
Date in BDB:
3/15/2019
Entry Details
US Patent

TargetTyrosine-protein kinase receptor UFO(Human)
Pfizer

US Patent
LigandChemical structure of BindingDB Monomer ID 300065BDBM300065(US9593097, Example 446 | US9593097, Example 445 | ...)
Affinity DataKi:  0.0410nMAssay Description:AXL enzyme inhibition (% inhibition, Kiapp and Ki values) by small molecule inhibitors was evaluated using a fluorescence-based microfluidic mobility...More data for this Ligand-Target Pair
In Depth
Date in BDB:
3/15/2019
Entry Details
US Patent

TargetTyrosine-protein kinase receptor UFO(Human)
Pfizer

US Patent
LigandChemical structure of BindingDB Monomer ID 299851BDBM299851(4-[4-({[2-amino-5- (1-methyl-1H- imidazol-4- yl)py...)
Affinity DataKi:  0.0420nMAssay Description:AXL enzyme inhibition (% inhibition, Kiapp and Ki values) by small molecule inhibitors was evaluated using a fluorescence-based microfluidic mobility...More data for this Ligand-Target Pair
In Depth
Date in BDB:
3/15/2019
Entry Details
US Patent

TargetTyrosine-protein kinase receptor UFO(Human)
Pfizer

US Patent
LigandChemical structure of BindingDB Monomer ID 300107BDBM300107(N-[(1R,2S)-2- hydroxycyclobutyl]- 6-[4-(4-methoxy-...)
Affinity DataKi:  0.0420nMAssay Description:AXL enzyme inhibition (% inhibition, Kiapp and Ki values) by small molecule inhibitors was evaluated using a fluorescence-based microfluidic mobility...More data for this Ligand-Target Pair
In Depth
Date in BDB:
3/15/2019
Entry Details
US Patent

TargetTyrosine-protein kinase receptor UFO(Human)
Pfizer

US Patent
LigandChemical structure of BindingDB Monomer ID 299995BDBM299995(4-[(1- cyanocyclopropyl) methoxy]-6-[4-(4- methoxy...)
Affinity DataKi:  0.0480nMAssay Description:AXL enzyme inhibition (% inhibition, Kiapp and Ki values) by small molecule inhibitors was evaluated using a fluorescence-based microfluidic mobility...More data for this Ligand-Target Pair
In Depth
Date in BDB:
3/15/2019
Entry Details
US Patent

TargetTyrosine-protein kinase receptor UFO(Human)
Pfizer

US Patent
LigandChemical structure of BindingDB Monomer ID 300091BDBM300091(N-[(3R,4S)-4- hydroxytetrahydro- furan-3-yl]-2- {[...)
Affinity DataKi:  0.0480nMAssay Description:AXL enzyme inhibition (% inhibition, Kiapp and Ki values) by small molecule inhibitors was evaluated using a fluorescence-based microfluidic mobility...More data for this Ligand-Target Pair
In Depth
Date in BDB:
3/15/2019
Entry Details
US Patent

TargetTyrosine-protein kinase receptor UFO(Human)
Pfizer

US Patent
LigandChemical structure of BindingDB Monomer ID 300065BDBM300065(US9593097, Example 446 | US9593097, Example 445 | ...)
Affinity DataKi:  0.0490nMAssay Description:AXL enzyme inhibition (% inhibition, Kiapp and Ki values) by small molecule inhibitors was evaluated using a fluorescence-based microfluidic mobility...More data for this Ligand-Target Pair
In Depth
Date in BDB:
3/15/2019
Entry Details
US Patent

Displayed 1 to 50 (of 435 total ) | Next | Last >>
Jump to: